These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2064202)
21. Effects of hormone therapy on the endometrium. Deligdisch L Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860 [TBL] [Abstract][Full Text] [Related]
22. Designing a schedule of progestin administration in the control of endometrial carcinoma growth in the nude mouse model. Mortel R; Zaino RJ; Satyaswaroop PG Am J Obstet Gynecol; 1990 Apr; 162(4):928-34; discussion 934-6. PubMed ID: 2327463 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
24. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium. Imai T; Kurachi H; Adachi K; Adachi H; Yoshimoto Y; Homma H; Tadokoro C; Takeda S; Yamaguchi M; Sakata M Biol Reprod; 1995 Apr; 52(4):928-38. PubMed ID: 7540053 [TBL] [Abstract][Full Text] [Related]
25. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148 [TBL] [Abstract][Full Text] [Related]
26. Increased extraction of estrogens in human endometrial hyperplasia and carcinoma. Bulletti C; Jasonni VM; Tabanelli S; Ciotti P; Cappuccini F; Borini A; Flamigni C Cancer Detect Prev; 1988; 13(2):123-30. PubMed ID: 3242821 [TBL] [Abstract][Full Text] [Related]
27. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium. Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400 [TBL] [Abstract][Full Text] [Related]
28. Distribution of basement membrane anchoring molecules in normal and transformed endometrium: altered expression of laminin gamma2 chain and collagen type XVII in endometrial adenocarcinomas. Määttä M; Salo S; Tasanen K; Soini Y; Liakka A; Bruckner-Tuderman L; Autio-Harmainen H J Mol Histol; 2004 Nov; 35(8-9):715-22. PubMed ID: 15609083 [TBL] [Abstract][Full Text] [Related]
29. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. Ehrlich CE; Young PC; Cleary RE Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531 [TBL] [Abstract][Full Text] [Related]
30. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression. Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160 [TBL] [Abstract][Full Text] [Related]
31. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303 [TBL] [Abstract][Full Text] [Related]
32. The effect of enzymes upon metabolism, storage, and release of carbohydrates in normal and abnormal endometria. Hughes EC Cancer; 1976 Jul; 38(1 SUPPL):487-502. PubMed ID: 819124 [TBL] [Abstract][Full Text] [Related]
33. Expression of carcinoembryonic antigen and ferritin in normal, hyperplastic, and neoplastic endometrium. Tsionou C; Minaretzis D; Papageorgiou I; Nakopoulou L; Michalas S; Aravantinos D Gynecol Oncol; 1991 Jun; 41(3):193-8. PubMed ID: 1869094 [TBL] [Abstract][Full Text] [Related]
34. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma. Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341 [TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma. Zhao S; Chen X; Lu X; Yu Y; Feng Y Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435 [TBL] [Abstract][Full Text] [Related]
36. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Xuebing P; TinChiu L; Enlan X; Jing L; Xiaowu H Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):198-203. PubMed ID: 21726930 [TBL] [Abstract][Full Text] [Related]
37. Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions. Houshdaran S; Chen JC; Vallvé-Juanico J; Balayan S; Vo KC; Smith-McCune K; Greenblatt RM; Irwin JC; Giudice LC Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283828 [TBL] [Abstract][Full Text] [Related]
38. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596 [TBL] [Abstract][Full Text] [Related]
39. Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Pan XY; Wang B; Che YC; Weng ZP; Dai HY; Peng W Int J Gynecol Cancer; 2007; 17(1):233-41. PubMed ID: 17291259 [TBL] [Abstract][Full Text] [Related]
40. Role of progesterone in endometrial cancer. Kim JJ; Chapman-Davis E Semin Reprod Med; 2010 Jan; 28(1):81-90. PubMed ID: 20104432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]